The use of insulin pumps as an innovative approach of diabetes therapy to improve glycemic control, patients' comfort of life and daily activity.
DOI:
https://doi.org/10.12775/JEHS.2024.76.56529Keywords
insulin pump, continous glucose monitoring, diabetes mellitus, insulin therapy, quality of lifeAbstract
Introduction and Purpose of Research.
There are diverse types of insulin pumps available, such as traditional pumps with tubing, tubeless pumps or continuous glucose monitoring (CGM) systems, pumps with automated insulin suspension. Diabetes complications lead to raised death rates, and overall decreased quality of life among patients. The aim of the study is to examine the impact of insulin pump usage including the effects on glycemic control, quality of life and limitations in daily life. Our work aims to emphasize the importance of using appropriate therapies in patients with diabetes.
Material and Methods.
The review was based on the analysis of materials collected in the Google Scholar and,, PubMed’’. The following keywords were entered during the search for scholarly articles: insulin pump, continuous glucose monitoring, quality of life, diabetes mellitus and insulin therapy. A total of 36 articles were considered for the study and verified for their relevance to the topic.
Brief description of the state of Knowledge.
The use of an insulin pump as an innovation can simplify tasks to manage the process and to maintain desired levels of blood glucose. Patients using a pump have more flexible possibilities regarding meals and diet. Additional non-health-related benefits, such as reduced worry about supplies while traveling, can significantly improve patients’ QoL as well activities, and community integration, as the pump aids in refining self-care habits.
Conclusions.
In this study, we investigated the impact of wearable technology of insulin pumps on metabolic management, the quality-of-life patients' comfort of life and daily activity in children and adolescents with diabetes. The quality of life can substantially increase when the performances of advanced devices and algorithms are associated with considerable support from family and healthcare providers.
References
1. Dilworth L, Facey A, Omoruyi F. Diabetes Mellitus and Its Metabolic Complications: The Role of Adipose Tissues. Int J Mol Sci. 2021 Jul 16;22(14):7644. doi: 10.3390/ijms22147644. PMID: 34299261; PMCID: PMC8305176.
2. Al-Beltagi M, Saeed NK, Bediwy AS, Elbeltagi R. Insulin pumps in children - a systematic review. World J Clin Pediatr. 2022 Nov 9;11(6):463-484. doi: 10.5409/wjcp. v11.i6.463. PMID: 36439904; PMCID: PMC9685680.
3. Umpierrez GE, Klonoff DC. Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital. Diabetes Care. 2018 Aug;41(8):1579-1589. doi: 10.2337/dci18-0002. Epub 2018 Jun 23. PMID: 29936424; PMCID: PMC6054505
4. Daly A, Hovorka R. Technology in the management of type 2 diabetes: Present status and prospects. Diabetes Obes Metab. 2021 Aug;23(8):1722-1732. doi: 10.1111/dom.14418. Epub 2021 May 20. PMID: 33950566; PMCID: PMC7611289.
5. Fisher L, Polonsky WH, Hessler D. Addressing diabetes distress in clinical care: a practical guide. Diabet Med. 2019 Jul;36(7):803-812. doi: 10.1111/dme.13967. Epub 2019 May 7. PMID: 30985025.
6. Davies MJ, D'Alessio DA, Fradkin J, Kernan WN, Mathieu C, Mingrone G, Rossing P, Tsapas A, Wexler DJ, Buse JB. Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2018 Dec;61(12):2461-2498. doi: 10.1007/s00125-018-4729-5. Erratum in: Diabetologia. 2019 May;62(5):873. doi: 10.1007/s00125-019-4845-x. PMID: 30288571.
7. Yen PM, Young AS. Review of Modern Insulin Pumps and the Perioperative Management of the Type 1 Diabetic Patient for Ambulatory Dental Surgery. Anesth Prog. 2021 Oct 1;68(3):180-187. doi: 10.2344/anpr-68-03-16. PMID: 34606570; PMCID: PMC8500319.
8. Biester T, Kordonouri O, Holder M, Remus K, Kieninger-Baum D, Wadien T, Danne T. "Let the Algorithm Do theWork": Reduction of Hypoglycemia Using Sensor-Augmented Pump Therapy with Predictive Insulin Suspension (SmartGuard) in Pediatric Type 1 Diabetes Patients. Diabetes Technol Ther 2017; 19: 173-182 [PMID: 28099035 DOI:.1089/dia.2016.0349]
9. Vettoretti M, Cappon G, Facchinetti A, Sparacino G. Advanced Diabetes Management Using Artificial Intelligence and Al-Beltagi M et al. Insulin pumps in children WJCP https://www.wjgnet.com 481 November 9, 2022, Volume 11 Issue 6 Continuous Glucose Monitoring Sensors. Sensors (Basel) 2020; 20 [PMID: 32664432 DOI: 10.3390/s20143870]
10. Haidar A, Smaoui MR, Legault L, Rabasa-Lhoret R. The role of glucagon in the artificial pancreas. Lancet Diabetes Endocrinol. 2016 Jun;4(6):476-9. doi: 10.1016/S2213-8587(16)30006-7. Epub 2016 Apr 29. PMID: 27138734.
11. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.
12. Urakami T. The Advanced Diabetes Technologies for Reduction of the Frequency of Hypoglycemia and Minimizing the Occurrence of Severe Hypoglycemia in Children and Adolescents with Type 1 Diabetes. J Clin Med. 2023 Jan 18;12(3):781. doi: 10.3390/jcm12030781. PMID: 36769430; PMCID: PMC9917934.
13. Doyle-Delgado K, Chamberlain JJ. Use of Diabetes-Related Applications and Digital Health Tools by People with Diabetes and Their Health Care Providers. Clin Diabetes. 2020 Dec;38(5):449-461. doi: 10.2337/cd20-0046. PMID: 33384470; PMCID: PMC7755044.
14. Calderon Martinez E, Castillo JL, Zachariah Saji S, Stein D, Khan TJ, Guardado Williams RF, Munguía ID, Arruarana VS, Velasquez K. Insulin Pump Therapy vs Multiple Daily Insulin Injections for Glycemic Control in Children with Type 1 Diabetes: A Systematic Review and Meta-Analysis. Cureus. 2024 Jan10;16(1): e52054. doi: 10.7759/cureus.52054. PMID: 38344584; PMCID: PMC10855014.
15. Freckmann G, Buck S, Waldenmaier D, Kulzer B, Schnell O, Gelchsheimer U, Ziegler R, Heinemann L. Insulin Pump Therapy for Patients with Type 2 Diabetes Mellitus: Evidence, Current Barriers, and New Technologies. J Diabetes Sci Technol. 2021 Jul;15(4):901-915. doi: 10.1177/1932296820928100. Epub 2020 Jun 1. Erratum in: J Diabetes Sci Technol. 2021 Jun 16:19322968211027984. doi: 10.1177/19322968211027984. PMID: 32476471; PMCID: PMC8258526.
16. Mbundu Ilunga R, Camponovo C, Le Dizès O, Wojtusciszyn A. Traitement par pompe à insuline : pour qui et comment le mettre en place en ambulatoire ? [Insulin pump treatment: For whom and how to set it up on an outpatient?]. Rev Med Suisse. 2020 Jun 10;16(697):1191-1196. French. PMID: 32520457.
17. Berget C, Messer LH, Forlenza GP. A Clinical Overview of Insulin Pump Therapy for the Management of Diabetes: Past, Present, and Future of Intensive Therapy. Diabetes Spectr 2019; 32: 194-204 [PMID: 31462873 DOI: 10.2337/ds18-0091]
18. Umpierrez GE, Klonoff DC. Diabetes Technology update: use of insulin pumps and continuous glucose monitoring in the hospital. Diabetes Care. 2018;41(8):1579-1589.
19. . Ginsberg BH. Patch pumps for insulin. J Diabetes SciTech Nol. 2019;13(1):27-33.
20. Campbell F, Lawton J, Rankin D, et al. Follow-Up Support for Efective type 1 Diabetes self-management (The FUSED Model): A systematic review and meta-ethnography of the barriers, facilitators and recommendations for sustaining self-management skills after attending a structured education programme. BMC Health Serv Res. 2018;18(1):898. https://doi. org/10.1186/s12913-018-3655-z
21. andau Z, Raz I, Wainstein J, Bar-Dayan Y, Cahn A. The role of insulin pump therapy for type 2 diabetes mellitus. Diabetes Metab Res Rev. 2017 Jan;33(1). doi: 10.1002/dmrr.2822. Epub 2016 Jun 21. PMID: 27189155.
22. Hermanns N, Lilly LC, Mader JK, Aberer F, Ribitsch A, Kojzar H, Warner J, Pieber TR. Novel simple insulin delivery device reduces barriers to insulin therapy in type 2 diabetes: results from a pilot study. J Diabetes Sci Technol. 2015 May;9(3):581-7. doi: 10.1177/1932296815570709. Epub 2015 Feb 9. PMID: 25670847; PMCID: PMC4604549.
23. Reznik Y, Cohen O, Aronson R, Conget I, Runzis S, Castaneda J, Lee SW; OpT2mise Study Group. Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial. Lancet. 2014 Oct 4;384(9950):1265-72. doi: 10.1016/S0140-6736(14)61037-0. Epub 2014 Jul 2. PMID: 24998009.
24. Pickup JC. Is insulin pump therapy effective in Type 1 diabetes? Diabet Med. 2019 Mar;36(3):269-278. doi: 10.1111/dme.13793. Epub 2018 Aug 29. PMID: 30098219
25. Benkhadra K, Alahdab F, Tamhane SU, McCoy RG, Prokop LJ, Murad MH. Continuous subcutaneous insulin infusion versus multiple daily injections in individuals with type 1 diabetes: a systematic review and meta-analysis. Endocrine. 2017;55(1):77–84. https://doi.org/10.1007/ s12020-016-1039-x.
26. Elian V, Popovici V, Ozon EA, Musuc AM, Fița AC, Rusu E, Radulian G, Lupuliasa D. Current Technologies for Managing Type 1 Diabetes Mellitus and Their Impact on Quality of Life-A Narrative Review. Life (Basel). 2023 Jul 30;13(8):1663. doi: 10.3390/life13081663. PMID: 37629520; PMCID: PMC10456000.
27. Ross LJ, Neville KA. Continuous subcutaneous insulin infusion versus multiple daily injections for type 1 diabetes. J Paediatr Child Health. 2019 Jun;55(6):718-722. doi: 10.1111/jpc.14480. PMID: 31155794.
28. Tzivian L, Sokolovska J, Grike AE, Kalcenaua A, Seidmann A, Benis A, Mednis M, Danovska I, Berzins U, Bogdanovs A, Syundyukov E. Quantitative and qualitative analysis of the quality of life of Type 1 diabetes patients using insulin pumps and of those receiving multiple daily insulin injections. Health Qual Life Outcomes. 2022 Aug 1;20(1):120. doi: 10.1186/s12955-022-02029-2. PMID: 35915454; PMCID: PMC9344781.
29. McCall AL, Farhy LS. Treating type 1 diabetes: from strategies for insulin delivery to dual hormonal control. Minerva Endocrinol 2013; 38: 145-163 [PMID: 23732369]
30. Bruttomesso D, Crazzolara D, Maran A, Costa S, Dal Pos M, Girelli A, Lepore G, Aragona M, Iori E, Valentini U, Del Prato S, Tiengo A, Buhr A, Trevisan R, Baritussio A. In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine. Diabet Med 2008; 25: 326-332 [PMID: 18307459 DOI: 10.1111/j.1464-5491.2007.02365.x]
31. Boucher-Berry C, Parton EA, Alemzadeh R. Excess weight gain during insulin pump therapy is associated with higher basal insulin doses. J Diabetes Metab Disord 2016; 15: 47 [PMID: 27777901 DOI: 10.1186/s40200-016-0271-5]
32. Breton MD, Kanapka LG, Beck RW, Ekhlaspour L, Forlenza GP, Cengiz E, Schoelwer M, Ruedy KJ, Jost E, Carria L, Emory E, Hsu LJ, Oliveri M, Kollman CC, Dokken BB, Weinzimer SA, DeBoer MD, Buckingham BA, Cherñavvsky D, Wadwa RP; iDCL Trial Research Group. A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes. N Engl J Med 2020; 383: 836-845 [PMID: 32846062 DOI: 10.1056/NEJMoa2004736]
33. Ghazanfar H, Rizvi SW, Khurram A, Orooj F, Qaiser I. Impact of insulin pump on quality of life of diabetic patients. Indian J Endocrinol Metab 2016; 20: 506-511 [PMID: 27366717 DOI: 10.4103/2230-8210.183472]
34. Codella R, Terruzzi I, Luzi L. Why should people with type 1 diabetes exercise regularly? Acta Diabetol 2017; 54: 615- 630 [PMID: 28289908 DOI: 10.1007/s00592-017-0978-x]
35. Quirós C, Bertachi A, Giménez M, Biagi L, Viaplana J, Viñals C, Vehí J, Conget I, Bondia J. Blood glucose monitoring during aerobic and anaerobic physical exercise using a new artificial pancreas system. Endocrinol Diabetes Nutr (Engl Ed) 2018; 65: 342-347 [PMID: 29483036 DOI: 10.1016/j.endinu.2017.12.012]
36. Thabit H, Lal R, Leelarathna L. Automated insulin dosing systems: Advances after a century of insulin. Diabet Med. 2021 Dec;38(12):e14695. doi: 10.1111/dme.14695. Epub 2021 Sep 28. PMID: 34547133; PMCID: PMC8763058.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Patrycja Łazicka, Julia Tarnowska, Eliza Jakubowska
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 79
Number of citations: 0
